Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 257

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 257
---
 3.0% of the gross proceeds from the sale of any shares of common stock. On December 31, 2020, the Mustang ATM was amended to add H.C. Wainwright & Co., LLC as an Agent. On April 14, 2023, the Mustang ATM was amended to add the limitations imposed by General Instruction I.B.6 to Form S-3 and remove Oppenheimer & Co., Inc. as an Agent. During the year ended December 31, 2023, the Company issued approximately 52,000shares of common stock at an average price of $ 3.15per share for gross proceeds of $ 163,000under the ATM Agreement. In connection with these sales, the Company paid aggregate fees of approximately $ 3,000for net proceeds of approximately $ 160,000. During the year ended December 31, 2022, the Company issued approximately 0.5million shares of common stock at an average price of $ 12.61per share for gross proceeds of $ 6.6million under the ATM Agreement. In connection with these sales, the Company paid aggregate fees of approximately $ 0.1million for net proceeds of approximately $ 6.5million. Pursuant to the Founders Agreement, the Company did not issue any shares of its common stock to Fortress for the year ended December 31, 2023, and recorded the value of 1,297shares issuable to Fortress in connection with the Mustang ATM. Pursuant to the Founders Agreement, Mustang issued 13,131shares of common stock to Fortress at a weighted average price of $ 13.56per share for the year ended December 31, 2022, in connection with the Mustang ATM. Registered Direct Offering On October 26, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single institutional accredited investor (the “Investor”) pursuant to which the Company agreed to issue and sell, in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “Registered Offering”), (i) 920,000shares of common stock, $ 0.0001par value per share, at a price per Share of $ 1.70and (ii) pre-funded warrants (the “Pre-funded Warrants”) to purchase up to 1,668,236shares of its common stock, at a price per Pre-funded Warrant equal to $